| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |